The combination of adagrasib and cetuximab may show clinical activity and promising survival outcomes in patients with metastatic, heavily pretreated, KRAS G12C–mutated colorectal cancer.
A recent study found that extreme Body Roundness Index levels significantly increase the risk of all-cause mortality among US adults, highlighting the importance of this measure in health assessments.
Adjuvant therapy may be underutilized in patients with clinical T2N0 rectal adenocarcinoma, according to new findings presented at Digestive Disease Week 2024.
A state-transition model demonstrates that multicancer early detection blood tests significantly reduce late-stage cancer diagnoses and mortality, with annual screening intervals showing superior outcomes compared to biennial testing.